nhs healthcare contracts

Community Cleaning contract for three locations

The East of England Ambulance Service NHS Trust (“The Authority”) is issuing an Invitation to Tender in connection with a competitive procurement for the Refurbishment of Hellesdon Roof.

NHS Central East (CE) ICB is seeking feedback on the provision of WorkWell Initiative Service in the CEICB region covering Bedfordshire, Luton and Milton Keynes, and Hertfordshire. In order to assist the Authority with testing its assumptions and proposed service requirements, interested organisations are requested to provide feedback on the information included within the documents. The draft service specification and supporting documents containing details of the requirement can be found in the attachments area of the project on the Atamis e-tendering portal. Please complete and return the completed MEQ template on Atamis e-tendering portal by 12 noon on 01st October 2026.

Motor Fleet Insurance Renewal-Policy No: BV29417552 Selected option 1: Allianz (Conventional Basis)

QEHKL239 Roof Re-covering Works and services

The Norfolk and Suffolk Integrated Care Board is looking to commission the University of Suffolk Dental and Student Education Service. This service will be a Personal Dental Services (PDS) Agreement (contract) to deliver primary care dental services, host placements and supervise undergraduates on the University of Suffolk BSc Dental Hygiene and Therapy course at the University of Suffolk James Hehir building in Ipswich.

HTE is seeking to establish a Dynamic Market for Taxi Services. The Dynamic Market will provide Participating Authorities the opportunity to carry out further competition between Tenderers who are admitted onto the Dynamic Market (“Admitted Tenderers”) for Taxi Services associated with the private hire and hackney carriage taxi services provide transportation for individuals or small groups on a regular, planned, or ad hoc, unplanned basis. The Dynamic Market will include Taxi Services and provision of associated technology and associated services which will support Participating Authorities with the delivery of their required Taxi Services to their stakeholders. Admitted Tenderers will be able to meet the relevant standards applicable to each of the areas covered by this Dynamic Market, as well as security standards, customer requirements and accreditation standards for the specific market. The Dynamic Market shall be one singular Lot for the provision of all taxi services and any associated services.

This is a UK1 pipeline notice only. Mid and South Essex NHS Foundation Trust (“the Authority”) intends to procure a managed service supporting Catheterisation Laboratories, Cardiothoracic and Vascular services across Basildon, Broomfield and Southend. The procurement is expected to be the first service-specific procurement within the Authority’s wider Managed Services Programme. The indicative scope may include equipment lifecycle planning and management; equipment supply, installation, commissioning, maintenance and uptime management; consumables and high-cost devices; inventory and supply chain management; digital integration and analytics; operational efficiency support; and appropriately defined on-site service support. The final scope, service boundaries, risk allocation and requirements will be confirmed in the tender notice and associated procurement documents. The proposed procurement forms part of the Authority’s wider Improving Value agenda and multi staged Managed Services Programme, which has been endorsed through the Authority’s governance arrangements. The intended outcomes include improved productivity, reduced operational variation, greater service resilience, modernised clinical infrastructure, improved asset utilisation and a more predictable revenue based approach to lifecycle investment. The procurement is also intended to support elective recovery, digital interoperability and operational efficiency. These intended outcomes remain subject to approval of the relevant business case and completion of the applicable assurance processes. The procurement will be conducted in accordance with the Procurement Act 2023 and the Procurement Regulations 2024. In carrying out the procurement, the Authority will have regard to the objectives of delivering value for money, maximising public benefit, sharing information to allow suppliers and others to understand the Authority’s procurement policies and decisions, and acting, and being seen to act, with integrity. The Authority will comply with the statutory duty to treat suppliers the same, together with the applicable requirements relating to conflicts of interest, exclusions, conditions of participation, assessment of tenders, contract award and publication of notices. The Authority’s current intention is to use the competitive flexible procedure under the Procurement Act 2023. Subject internal approvals and finalisation of the procurement documents, the procedure is expected to include a structured negotiation stage to include: 1. Assessment of suppliers against the conditions of participation 2. Invitation to submit initial tenders 3. Negotiation with selected suppliers 4. Invitation to submit final tenders The tender notice and associated procurement documents will set out the final procedure, including the conditions of participation, minimum requirements, award criteria, assessment methodology, stages of the procedure, any limits on the number of participating suppliers, the basis for progression or down selection, the scope of any negotiation, and any reserved rights to amend, suspend or terminate the procedure. Any such reserved right will be exercised transparently, proportionately and in accordance with the Procurement Act 2023 and the Procurement Regulations 2024, including the duties to treat suppliers the same and not to put any supplier at an unfair advantage or disadvantage. The indicative initial contract term is ten years, from 1 September 2028 to 31 August 2038. The Authority currently anticipates including an option to extend the contract for up to a further five years, potentially to 31 August 2043. Any extension would be exercised at the Authority’s discretion and would be subject to satisfactory performance, continuing affordability, value for money, service requirements, the contractual extension provisions and completion of the Authority’s applicable governance and gateway approvals. The procurement will be subject to the Authority’s applicable governance, business case approval and assurance requirements, including any relevant requirements of NHS England, the Department of Health and Social Care, HM Treasury and the Cabinet Office. All information in this pipeline notice, including the scope, procedure, estimated dates and contract term, is indicative and may change as the procurement develops. The Authority will keep the information under review and will update or correct the notice where appropriate. This notice does not commence a competitive tendering procedure, constitute an invitation to tender or create any commitment by the Authority to proceed with the procurement. Suppliers should rely on the subsequently published tender notice and associated procurement documents for the definitive requirements and procedure. Indicative procurement timetable: • Outline Business Case (OBC) assurance and approval — By 28 January 2027 • Publication of the tender notice and commencement of the competitive flexible procedure — February 2027 • Conditions of participation stage — February to April 2027 • Initial tender stage — April 2027 • Negotiation stage — June 2027 • Final tenders and preferred bidder selection — July to August 2027 • Final Business Case (FBC) and final approvals — September to November 2027 • Contract award and mobilisation — Mid November 2027 to August 2028 • Service go-live — 1 September 2028 The dates above are the Authority’s current estimates and may change as the business case, assurance, governance and procurement planning progress. Updated timing will be provided through subsequent notices and procurement documents where appropriate.

NHS Norfolk and Suffolk Integrated Care Board (ICB) and Norfolk and Suffolk NHS Mental Health Trust intend to procure an outcomes-focused Mental Health Wellbeing Hub Model and Crisis at Home and Crisis Outside of the Home Service across the Norfolk and Suffolk localities. Commissioning will be undertaken through an outcomes-based approach, with providers required to develop and propose a delivery model that demonstrates how the specified service functions and outcomes will be achieved across Norfolk and Suffolk.

Body Storage Contingency

Provision of a deceased contingency storage and transfer service for Mid and South Essex NHS Foundation Trust (MSEFT), including flexible mortuary storage capacity, transportation of deceased between Trust mortuary sites and contingency facilities, bariatric transfers, and support during periods of increased demand. The contract includes governance, audit, incident management, and performance review requirements, commencing on 11 January 2027 for an initial 3-year term ending 10 January 2030, with the option to extend for up to 24 months.

Managed Service for the Provision of Renal Dialysis Services to ESNEFT including Unit, Satellite and Home Haemodialysis, Peritoneal Dialysis and associated support

NICE approved digital specialist weight management service for full integration into ESNEFT Complex Obesity Service for delivery of various MDT and non-MDT GLP-1 medication pathways The Authority reserves the right not to proceed to procurement where it is determined that the service is no longer required, alternative delivery arrangements are available, existing contractual extension provisions can be utilised, or for any other operational, commercial, or strategic reason.

NHS Norfolk and Suffolk Integrated Care Board (ICB) intends to procure an outcomes-focused Dementia Support Service that acts as a strategic neighbourhood partner across the dementia pathway within the Norfolk and Waveney locality. The service will contribute to improved population health outcomes, reduced health inequalities, increased community resilience and improved integration between primary care, community services, mental health, social care and the voluntary, community and social enterprise sector. The procurement will support delivery of the ICB's Ageing Well and Population Health Management priorities, enabling people living with dementia and their carers to remain independent, connected and well for as long as possible.

Suffolk County Council (Public Health, Communities and Public Safety) is undertaking a soft market testing questionnaire to inform a potential future procurement for the postal supply of Nicotine Replacement Therapy (NRT) and smoking cessation prescription medication. Smoking prevalence in Suffolk is currently estimated at 10.5%. The Council's ambition is to reduce this to 5% or below by 2030. NRT and prescribed smoking cessation medications are recognised as effective interventions to support people to quit smoking and remain an important element of the local stop smoking offer. The Council currently provides access to these products through a pharmacy-based pathway. However, not all clients are able to access participating pharmacies due to factors such as working hours, limited transport options or mobility issues. The Council is therefore exploring alternative delivery models to improve accessibility. The Council is considering a procurement comprising two lots. Suppliers may bid for either lot individually or for both lots. Lot 1 - Nicotine Replacement Therapy (NRT) Supply a range of NRT products following referral from the Council's commissioned stop smoking service (FGS) and deliver products directly to clients using a reliable and secure postal service. Lot 2 - Smoking cessation prescription medication Undertake remote clinical consultations with clients referred by the stop smoking service to assess suitability for Varenicline or Cytisine and, where clinically appropriate, supply medication directly to clients using a reliable and secure postal service. This exercise is exploratory and non-evaluative. It is intended to inform the Council's understanding of market capability, potential delivery models, implementation timescales and indicative costs. The anticipated contract value is approximately £400,000 (approximately £100,000 per annum) for an initial two-year contract with the option to extend for up to a further two years. This notice does not constitute a call for competition or a commitment to procure.

This Prior Information Notice (PIN) is intended to notify the market of the Market Engagement event only. This PIN is NOT a call for competition.<br/><br/>NHS Essex Integrated Care Board (hereafter referred to as "the Authority") invites suitably qualified providers to attend a virtual Market Engagement event which will inform the market of the Authority's intention to undertake a competitive procurement process for the provision of WorkWell, Work and Health Support Services on Thursday 6th August 2026 10:0hrs - 11.30hrs<br/><br/>The Authority provides health and care to 1.9 million residents covering the geographical footprint of Essex, including Southend and Thurrock.<br/><br/>The commissioning model will comprise of Local WorkWell Partnerships and a single Essex-wide WorkWell Neighbourhood Work and Health Coach Service, with delivery designed around local government reorganisation footprints and strengthened access at key intervention points, including GP surgeries where Fit Notes are commonly created and maintained. <br/><br/>The programme expects to include a WorkWell Assistance Programme that, in combination with Neighbourhood Work and Health Coaches, supports early intervention. <br/><br/>The Authority intends to procure the new 'WorkWell Service' provision and award appropriate contracts to suitable, technically capable providers. To award the contracts, the most suitable providers must have demonstrably satisfied the minimum Basic Selection Criteria, including financial and economic standing, and satisfy the Key Criteria assessment and the commercial envelope.<br/><br/>The market engagement event will offer an opportunity to engage with stakeholders and for prospective service providers to learn more about the services. The procurement process and timetable will also be shared.<br/><br/>The Market Engagement event will take place virtually via MS Teams Webinar on Thursday 6th August from 10.00hrs – 11.30hrs. <br/><br/>To express interest and participate in the Market Event, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome <br/>The relevant documentation will be available within the “C460866 WorkWell Services” project. <br/><br/>It is free to register on the Atamis portal and it can be accessed at any time of day providing you have a working internet connection. Should providers have any queries, or are having problems registering on the portal; they should contact the Atamis helpdesk via: [email protected] or phone number 0800 9956035. The helpdesk is open Monday - Friday between 08:0 - 18:0<br/>The deadline for expressions of interest is 17:30hrs on Wednesday 05th August 2026. If you have any questions, please send them through the message centre on the Atamis e-procurement portal.<br/><br/>The Authority has published this PIN to support market engagement for this WorkWell Services only. Any future procurement opportunities pertaining to these services, if undertaken, will be advertised with a separate call for competition via a relevant notice published in the Central Digital Platform (CDP) and all appropriate platforms, once final.

Cambridge University Hospitals NHS Foundation Trust (CUH) seeks to engage with potential suppliers via this Preliminary Market Engagement (PME) exercise to seek feedback and information to inform the forthcoming procurement of a comprehensive Digital Pathology Solution for the Department of Histopathology and Diagnostic Cytology and Haemato-oncology departments at Addenbrooke's Hospital, Cambridge Biomedical Campus. CUH is part of the Mid-East-5 Pathology Network, which also includes North West Anglia NHS Foundation Trust and Bedfordshire NHS Foundation Trust. The network is interested in how closer collaboration over Histopathology can be achieved and are considering potential for jointly approaching this procurement to enable a closer working model to be achieved through common digital technology and interoperability. CUH is a Comprehensive Cancer Centre (CCC) and one of the largest NHS teaching hospital trusts in England. The Department processes approximately over 2000 slides per working day, including H&E, immunohistochemistry (IHC), in-situ hybridisation (ISH), special stains and an 8% annual growth rate projected. The laboratory is working towards running a fully automated pre-analytical and microtomy workflow including the Inpeco Flexpath system; Dainippon Seiki AT-192 trimmer and AS-410M sectioner distributed by Axlab UK, IHC platforms (Leica BOND-III,Leica BOND-PRIME and Ventana BenchMark Ultra Plus), HE staining equipment (Leica Spectra ST and CV), and Epic Beaker as its LIMS. The current digital pathology system includes the Philips SG300, Objective imaging Glissando and the Philips Image management System. The anticipated requirements include: • Whole Slide Imaging (WSI) scanner fleet achieving a minimum aggregate throughput of 400 slides per hour at 40x equivalent resolution or better (0.25 um/pixel minimum) for CE/UKCA-cleared primary diagnostic use, compatible with H&E, IHC, ISH, special stains and cytological preparations • Image Management System (IMS) providing primary diagnostic reporting, zero-footprint web viewer, bidirectional Epic Beaker integration, and an open AI integration framework for future CE/UKCA-cleared third-party AI algorithm integration without proprietary marketplace lock-in. IMS allowing integration of Macro/Block photography and associated to the Epic Beaker accession number for specimen/block/ slide comparison • AI-enabled Quality Control (QC) module operating pre-release to the reporting worklist, covering H&E, IHC, and special stains with stain-specific configurable thresholds, integrated rescan workflow and CE/UKCA IVD-MD SaMD regulatory clearance • Scalable petabyte-class whole slide image storage with UK data residency throughout the contract term, Minimum 1.2 PB usable capacity at contract start, scalable to 7 PB by Year 7. Suppliers may propose on-premise, cloud (UK data centres only), hybrid or nationally managed storage solutions. Solutions that provide or connect to national NHS digital pathology storage programmes are encouraged to describe this capability and the terms of access • Secure, standards-based whole slide image sharing to support: (a) intra-NHS sharing across pathology services enabling rapid second opinion and regional MDT collaboration, without requiring bilateral configuration with each receiving organisation; (b) external sharing to national and international second-opinion centres, academic institutions and clinical trial sponsors via DICOM or encrypted time-limited links without VPN access; (c) receipt and viewing of inbound images from external senders. All transfers must be encrypted with access audit logging and link expiry controls. Suppliers providing or connecting to national NHS digital pathology image exchange programmes are encouraged to describe this capability and the interoperability standards supported; (d) de-identified image sharing with annotation for research purposes; (e) Ability to audit access of shared images/ cases • Workload management and analytics dashboard: scanner throughput monitoring against a fleet target of >=400 slides/hr, pathologist workload allocation, TAT analytics, error logs and SLA management • AI Diagnostic Integration Framework: open vendor-neutral API enabling future procurement and integration of CE/UKCA-cleared diagnostic AI algorithms without full platform replacement. Note: diagnostic AI algorithms are not being procured under this notice The Authority welcomes responses from all supplier types including individual vendors and consortia, established major providers of digital technology solutions, Small and Medium-sized Enterprises (SMEs) and niche innovators. Suppliers may respond to the full scope or to individual component areas. The Authority does not pre-determine the delivery model and is open to end-to-end solutions, modular proposals, and solutions that leverage established national NHS infrastructure, provided all requirements set out in this notice are demonstrably met. The Authority wishes to engage the market on the following specific points: • Market capability for high-throughput WSI scanning at >=400 slides/hour at 40x for CE/UKCA primary diagnosis, including emerging entrants • Market capability for specialist scanner with the capability for minimum 60x scanning, polarisation and full z-stack scanning • CE/UKCA IVD-MD primary diagnosis regulatory status of IMS platforms in the UK and timeline for platforms where clearance is in progress • Capability to integrate with national NHS digital pathology storage and image exchange programmes via DICOM standards including whether proposed IMS and storage solutions support interoperability with established national NHS infrastructure without mandating a specific viewer or IMS platform at the receiving end • Open AI framework maturity: vendor-neutral for CE/UKCA third-party diagnostic AI integration; confirmed partner integrations with Paige, Ibex, Visiopharm, PathAI or equivalent; multi-algorithm-per-slide support • Epic Beaker integration maturity: confirmed bidirectional HL7/FHIR at scale; existing Epic Beaker reference sites • UK field service and support infrastructure for 7-year contract: engineer response times; parts availability guarantee; preventive maintenance programme • Available commercial models: capital purchase, managed service, pay-per-scan, reagent-rental equivalent; indicative pricing for 7-year contract at stated volumes • Social value commitments and NHS Net Zero aligned carbon reduction pathways

Hertfordshire Partnership University NHS Foundation Trust (HPFT) is currently developing a new 'Support in the Community Framework' for the provision of community-based support and homecare services for adults with mental health needs. This will be a competitive procurement process, delivered in line with the Procurement Act 2023, and will introduce a structured framework with defined service levels, geographical lots and agreed rates to support a sustainable, high-quality provider market across Hertfordshire. HPFT anticipate the duration of the framework to be for 8 years and will be re-opened every 2 years. This tender is being run via the Atamis portal: https://health-family.force.com/s/Welcome •Suppliers should register on the portal if not already registered. •To express an interest in this preliminary market engagement, search and select contract reference: C455508 HPFT Social Care in the Community •Suppliers can contact the Atamis helpdesk at – [email protected] or by calling 0800 9956035 for technical assistance.

Hertfordshire County Council (the Council) is carrying out PME in relation to the Development of Nursing Home Care Provision in Hertfordshire programme. The Council will consider the feedback received to shape the Council’s options, requirements and further decision making. For the avoidance of doubt, this stage of the project is not part of a formal procurement process, and the Council is not committing, at this stage, to carrying out such a process. The Council has created a detailed care provider prospect which is published as part of the PME outlining the opportunity and programme aims, as well as signposting key areas where care provider feedback can play a central role in shaping the nursing homes service model and ensuring they are designed and operated to meet the needs of our residents now and in the future. Please refer to these documents for more detailed information on the programme. At the heart of this programme is Hertfordshire County Council's Connected Lives approach. We believe that people requiring nursing care, should continue to have opportunities to maintain relationships, make choices about their lives, participate in their communities and enjoy the best possible quality of life. The Council is progressing a Social Investment Model to support the delivery of additional nursing home capacity in Hertfordshire. Under this innovative model, investors and developers would fund and build 6-8 new homes, the Council would enter into long-term lease arrangements for completed buildings, and the homes would then be sub-leased to registered care providers responsible for delivering high quality nursing dementia care with an agreed number of beds allocated for LA use at its normal fee rates. The Council are aiming to understand how we can expand nursing care bed capacity, improve long term sustainability of both our provider and our wider market, and ensure our residents can access modern, affordable and high quality accommodation that meets their needs local to where they live and have a home for life wherever possible. Participation or non-participation in the PME shall not prevent any supplier participating in a potential future procurement, nor is it intended that any information supplied as part of the PME shall place any supplier at an advantage in a potential procurement process. For further information, please see the PME Document, Prospectus Document and Questionnaire.

Cambridge University Hospitals (CUH) seeks to engage with potential suppliers via this Preliminary Market Engagement exercise to seek feedback and information to the provision of Flow Cytometry Instrumentation and Reagents to CUH. Clinical flow cytometry is currently performed within the Haematopathology and Oncology Diagnostic Service (HODS) and Immunology departments based in 2 separate locations at Addenbrookes's Hospital. 1. The HODS service is a regional specialist integrated diagnostic and follow-up service for Haematological neoplasms, serving a population of approximately 4 million. HODS perform a wide range of highly complex flow cytometry assays (8-10 colours) including those for monitoring minimal residual disease (MRD). Current workload is around 20,000 assays per year. 2. Immunology at CUH provide a routine diagnostic service of nearly 6,000 tests a year. In collaboration with Clinical and research teams across the Trust, Immunology are expanding their existing repertoire, to support diagnosis of Hemophagocytic Lymphohistiocytosis (HLH). The requirements are anticipated to include: - Provision of flow cytometry instrumentation (at least two separate flow cytometry systems will be required due to location of clinical laboratories) - Provision of reagents to support a wide range of diagnostic assays across the two services - Provision of pre-analytical automation solutions - Digital connectivity solutions including off-line analysis and integration into EPIC EPR. The Authority wishes to involve the market in discussing the following general points: - Current market and market interest in this project - Available contracting models (incl. reagent rental and lease agreement) - Currently available or novel solutions for refining the whole workflow process through pre-analytical, analytical, post analytical phases - Innovation and opportunities (for example Spectral Flow Cytometry)